Literature DB >> 33829370

Can drug-induced sleep endoscopy (DISE) predict compliance with positive airway pressure therapy? A pilot study.

Mariane S Yui1, Quedayr Tominaga1, Bruno C P Lopes2, Alan L Eckeli3, Leila A de Almeida3, Fabio A W Rabelo4, Daniel S Küpper1, Fabiana C P Valera5.   

Abstract

PURPOSE: Drug-induced sleep endoscopy (DISE) has been poorly explored as an examination to assess positive airway pressure (PAP) therapy in patients with obstructive sleep apnea (OSA). The present study aimed to identify by DISE possible characteristics related to low compliance with PAP therapy due to respiratory complaints.
METHODS: Patients using PAP for OSA underwent DISE in two conditions: (1) baseline (without PAP) and (2) PAP (with the same mask and airway pressure used at home). We compared patients reporting low compliance to PAP due to respiratory complaints to those well-adapted to therapy. VOTE classification (assessment of velopharynx, oropharynx, tongue base, and epiglottis) and TOTAL VOTE score (the sum of VOTE scores at each anatomical site) were assessed. ROC curve analyzed the accuracy of TOTAL VOTE to predict low compliance due to persistent pharyngeal obstruction in both conditions.
RESULTS: Of 19 patients enrolled, all presented multilevel pharyngeal obstruction at baseline condition, with no difference between groups at this study point. When PAP was added, the median VOTE value was higher in the epiglottis (P value=0.02) and tended to be higher at the velum and tongue base in the poorly adapted group; TOTAL VOTE score was also significantly increased in patients with low compliance (P value<0.001). ROC curve demonstrated that patients with TOTAL VOTE scored 2.5 or more during DISE with PAP presented a 4.6-fold higher risk for low compliance with PAP therapy due to pharyngeal obstruction (AUC: 0.88±0.07; P value<0.01; sensitivity: 77%; specificity: 83%).
CONCLUSIONS: Adding PAP during a DISE examination may help to predict persistent pharyngeal obstruction during PAP therapy.
© 2021. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Keywords:  Adaptation; Apnea; Compliance; Drug-induced sleep endoscopy; OSA; Obstructive sleep apnea; PAP; VOTE

Mesh:

Substances:

Year:  2021        PMID: 33829370     DOI: 10.1007/s11325-021-02360-w

Source DB:  PubMed          Journal:  Sleep Breath        ISSN: 1520-9512            Impact factor:   2.816


  27 in total

1.  Does drug-induced sleep endoscopy change the treatment concept of patients with snoring and obstructive sleep apnea?

Authors:  Corlette Eichler; J Ulrich Sommer; Boris A Stuck; Karl Hörmann; Joachim T Maurer
Journal:  Sleep Breath       Date:  2012-01-22       Impact factor: 2.816

2.  Symptoms During CPAP Therapy Are the Major Reason for Contacting the Sleep Unit Between Two Routine Contacts.

Authors:  Heidi Avellan-Hietanen; Pirkko Brander; Adel Bachour
Journal:  J Clin Sleep Med       Date:  2019-01-15       Impact factor: 4.062

3.  Drug-induced sleep endoscopy in sleep-disordered breathing: report on 1,249 cases.

Authors:  Anneclaire V Vroegop; Olivier M Vanderveken; An N Boudewyns; Joost Scholman; Vera Saldien; Kristien Wouters; Marc J Braem; Paul H Van de Heyning; Evert Hamans
Journal:  Laryngoscope       Date:  2013-12-11       Impact factor: 3.325

4.  Nonresponders to pharyngeal surgery for obstructive sleep apnea: insights from drug-induced sleep endoscopy.

Authors:  Eric J Kezirian
Journal:  Laryngoscope       Date:  2011-05-06       Impact factor: 3.325

5.  Evaluation of drug-induced sleep endoscopy as a patient selection tool for implanted upper airway stimulation for obstructive sleep apnea.

Authors:  Olivier M Vanderveken; Joachim T Maurer; Winfried Hohenhorst; Evert Hamans; Ho-Sheng Lin; Anneclaire V Vroegop; Clemens Anders; Nico de Vries; Paul H Van de Heyning
Journal:  J Clin Sleep Med       Date:  2013-05-15       Impact factor: 4.062

6.  Effects of continuous positive airway pressure on neurocognitive function in obstructive sleep apnea patients: The Apnea Positive Pressure Long-term Efficacy Study (APPLES).

Authors:  Clete A Kushida; Deborah A Nichols; Tyson H Holmes; Stuart F Quan; James K Walsh; Daniel J Gottlieb; Richard D Simon; Christian Guilleminault; David P White; James L Goodwin; Paula K Schweitzer; Eileen B Leary; Pamela R Hyde; Max Hirshkowitz; Sylvan Green; Linda K McEvoy; Cynthia Chan; Alan Gevins; Gary G Kay; Daniel A Bloch; Tami Crabtree; William C Dement
Journal:  Sleep       Date:  2012-12-01       Impact factor: 5.849

7.  Sleep endoscopy with simulation bite for prediction of oral appliance treatment outcome.

Authors:  Anneclaire V M T Vroegop; Olivier M Vanderveken; Marijke Dieltjens; Kristien Wouters; Vera Saldien; Marc J Braem; Paul H Van de Heyning
Journal:  J Sleep Res       Date:  2012-12-04       Impact factor: 3.981

8.  Practice parameters for the use of continuous and bilevel positive airway pressure devices to treat adult patients with sleep-related breathing disorders.

Authors:  Clete A Kushida; Michael R Littner; Max Hirshkowitz; Timothy I Morgenthaler; Cathy A Alessi; Dennis Bailey; Brian Boehlecke; Terry M Brown; Jack Coleman; Leah Friedman; Sheldon Kapen; Vishesh K Kapur; Milton Kramer; Teofilo Lee-Chiong; Judith Owens; Jeffrey P Pancer; Todd J Swick; Merrill S Wise
Journal:  Sleep       Date:  2006-03       Impact factor: 5.849

9.  Type of mask may impact on continuous positive airway pressure adherence in apneic patients.

Authors:  Jean Christian Borel; Renaud Tamisier; Sonia Dias-Domingos; Marc Sapene; Francis Martin; Bruno Stach; Yves Grillet; Jean François Muir; Patrick Levy; Frederic Series; Jean-Louis Pepin
Journal:  PLoS One       Date:  2013-05-15       Impact factor: 3.240

10.  Adherence of obstructive sleep apnea syndrome patients to continuous positive airway pressure in a public service.

Authors:  Danielle L C Queiroz; Mariane S Yui; Andréa A Braga; Mariana L Coelho; Daniel S Küpper; Heidi H Sander; Leila A Almeida; Regina M F Fernandes; Alan L Eckeli; Fabiana Cardoso Pereira Valera
Journal:  Braz J Otorhinolaryngol       Date:  2014-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.